About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 906 record(s)
Req # A-2023-000957
All information released as part of Freedom of Information (FOI) request number A-2016-000527, completed by your office around April 1, 2019. All documents related to a decision made by the Minister of Health, announced on April 4, 2016 to cancel work on policy and regulations regarding Tamper-Resistance Formulations of Opioid Drug Products.Organization: Health Canada
October 2023
Req # A-2019-002076
Adverse Drug Reaction (ADR). Report number: E2B_02697540.Organization: Health Canada
October 2023
Req # A-2023-22
A copy of reports C.6086 (Tropicalization of Army Medical Stores), C.6138 (Tropicalization of Medical Stores), as well as any report focusing on tropicalization and entomology produced between 1939 and 1947.Organization: National Research Council Canada
October 2023
Req # A-2023-143
The annual remuneration of the members of the board of directors of the Port of Québec as well as that of its CEO Mario Girard including bonuses and marginal profits.Organization: Quebec Port Authority
October 2023
Req # A-2023-000313
The licensed indications for use for MicroTheurapeutic‘s Axium Embolization Coils on Medical Device License 63475 that Health Canada has on file for this license.Organization: Health Canada
September 2023
Req # A-2023-000713
A copy of all information released as part of Freedom of Information (FOI) request number A-2016-00717, completed by your office around October 1, 2016.Organization: Health Canada
September 2023
Req # A-2021-000663
Adverse Drug Reaction (ADR) for HYOSCINE BUTYLBROMIDE. Report number: E2B_03293753.Organization: Health Canada
September 2023
Req # A-2022-001661
Adverse Drug Reaction (ADR). Report number: E2B_05716216.Organization: Health Canada
September 2023
Req # A-2023-000352
Adverse Drug Reaction (ADR) for LANREOTIDE. Report number: E2B_05322380.Organization: Health Canada
September 2023
Req # A-2023-000381
Adverse Drug Reactions (ADRs) for ZOSTAVAX II. Report numbers: E2B_03009425, E2B_01335934, E2B_02096585, E2B_01892634, E2B_02393844, E2B_02387551, E2B_02826826, E2B_02867073, E2B_02455143, E2B_03044908.Organization: Health Canada
September 2023